Muscular abnormalities in liver cirrhosis

Area of Science:

• Hepatology and Geriatrics
• Muscle Physiology and Disease

Background:

• Sarcopenia is increasingly recognized as a critical factor in the clinical evaluation of chronic liver disease (CLD).
• Growing evidence links sarcopenia to adverse outcomes in CLD, including disease decompensation, extended hospital stays, and increased mortality.
• Sarcopenia assessment aids in prioritizing patients for liver transplantation.

Purpose of the Study:

• To review and present recent data on diagnostic methods for early sarcopenia detection in CLD patients.
• To critically evaluate the accuracy, reliability, merits, and weaknesses of various existing sarcopenia assessment tools.
• To provide an overview of the current landscape, highlighting key discoveries and areas needing further clarification.

Main Methods:

• Literature review of recently published data on sarcopenia diagnosis in chronic liver disease.
• Critical analysis of diverse evaluation methods, considering their accuracy and reliability.
• Synthesis of findings to present a comprehensive overview of diagnostic modalities.

Main Results:

• Various methods exist for diagnosing sarcopenia, each with distinct advantages and limitations.
• The clinical significance of sarcopenia in CLD is supported by data linking it to decompensation, hospitalization, and mortality.
• Early and accurate diagnosis is essential for effective patient management and treatment stratification.

Conclusions:

• A well-founded approach to diagnosing sarcopenia is essential in daily clinical practice for CLD patients.
• Further research is needed to clarify ambiguities and establish definitive diagnostic standards.
• Key unanswered clinical questions remain regarding sarcopenia's role and management in chronic liver disease.